About MSKCC

Share
Print
Share
Print
Photo of Jeffrey Drebin, MD, PhD, Surgeon

MSK specialists have developed many of the practices that are used at top cancer hospitals around the world.

Memorial Sloan Kettering Cancer Center (MSKCC) is the world’s oldest and largest private cancer center. For more than 135 years, the cancer experts at MSKCC have kept patients at the center of everything we do, from caring for the people we treat to innovative research to outstanding educational programs.

Our mission is to prevent, control, and ultimately cure cancer. That is the shared commitment of our more than 1,300 doctors, 4,500 nurses, and over 14,500 support staff.

For more than 30 years, MSKCC has been rated as one of the top two cancer hospitals in America by U.S. News & World Report, the most recognized ranking of healthcare facilities in America. MSKCC is also one of the charter members of the National Cancer Institute’s designated Comprehensive Cancer Centers. Research shows these centers provide cancer patients with the best outcomes.    

Exceptional Patient Care and Cancer Expertise

Cancer is not a single disease. Instead, there are more than 400 different types of cancer, requiring the expertise of specialists. Our experts are organized into multidisciplinary Disease Management Teams that collaborate to develop personalized treatment plans for each patient. These specialists share one goal: to provide compassionate care so each patient can achieve the best possible outcome while reducing the impact of therapy to maintain quality of life during and after treatment. 

Lifesaving Cancer Innovations

MSKCC scientists and doctors have developed and pioneered many of today’s most important advances in treating cancer. In the field of immunotherapy, studies began at MSKCC more than a century ago. Since then, our scientists have led the effort to develop treatments that harness the body’s own immune system to destroy cancer. Among many advances in immunotherapy, MSKCC physician-scientists have played key roles in developing monoclonal antibodies, checkpoint inhibitors, and CAR T cell therapy. These innovations in immunotherapy are changing the treatment of melanoma, leukemia and lymphoma, lung, bladder, kidney and many other cancers.

Access an MSKCC Expert
The specialists at MSKCC India are here to help you. Find out more to see if MSKCC is right for you.